G

Grace Therapeutics Inc
D

GRCE

3.54000
USD
-0.06
(-1.67%)
مغلق
حجم التداول
1,810
الربح لكل سهم
-1
العائد الربحي
-
P/E
-7
حجم السوق
54,778,052
المقالات

العنوان: Grace Therapeutics Inc

القطاع: Healthcare
الصناعة: Biotechnology
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage. Other products are GTx-102 Ataxia-Telangiectasia, GTx-101 Postherpetic Neuralgia, and GTx-201.